ZyVersa Therapeutics, Inc. (ZVSA) NASDAQ

0.53

-0.044(-7.70%)

Updated at May 09 04:00PM

Currency In USD

Valuation

Market Cap11.77M
Enterprise Value10.24M
P/E Ratio-0
PEG Ratio-0
Price/Sales Ratio73.17
Price/Book Ratio0
Enterprise/Revenue14.47
Enterprise/EBITDA-0.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-92,348.65
Operating Margin-350.37

Management Effectiveness

Return On Assets-116.91
Return On Equity-1.13

Income Statement

Revenue0
Revenue/Share0.02
Gross Profit0
EBITDA-9.14B
Net Income-9.41B
Diluted EPS-848.03

Balance Sheet

Total Cash1.53M
Total Cash/Share1.41
Total Debt0
Total Debt/Equity0
Current Ratio0.15
Book Value Per Share7.85

Price History

52-Week Change-90.18
52-Week High6.3
52-Week Low0.47
Moving Average 50 Days0.78
Moving Average 200 Days1.66

Statistics

Average Volume3.53M
Shares Outstanding3.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateApril 26, 2024